Previous Page  37 / 218 Next Page
Information
Show Menu
Previous Page 37 / 218 Next Page
Page Background

35

General introduction

processing during the execution of the rewarded task-switching paradigm (

box 2.3

). To this

end, I compared a group of adults who were diagnosed with ADHD with a group of subjects

without ADHD while they performed the rewarded task switching paradigm in a functional

MRI environment (

box 2.4

). Effects of dopamine in these patients were assessed by testing the

patients both after their normal dose of methylphenidate (i.e. after Ritalin®, or an equivalent

dose of Ritalin for those usually taking Concerta®;

box 2.2b

) and after withdrawal from their

normal medication (

box 2.2b

). This enabled me to assess whether ADHD medication affects

the integration of motivation and cognitive control signals. Further, to account for inter-

individual differences in task performance and neural processing during this task (Aarts et

al., 2010), individual variability in the dopamine transporter genotype was taken into account

(

box 2.2c

). The results revealed that ADHD was accompanied by excessive signalling in the

striatum when patients had not taken their medication. However this effect depended on

the

DAT1

genotype, and was only present in a subset of patients. In addition, this excessive

striatal response was normalized after intake of methylphenidate. Surprisingly however, we

did not replicate the previous observation that motivated cognitive control varies according

to the

DAT1

genotype in healthy subjects ((Aarts et al., 2010) and

chapter 3

). One major

difference between these studies was the age of the subjects: those in

chapter 3

were ~22

years old, whereas the control group in

chapter

4

was on average 38 years old. In

chapter

5

I therefore aimed to assess whether the age of the participants could indeed explain the

differences between these studies.